EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS133-02477 
Organism
Homo sapiens 
Tissue/cell
melanoma 
Coordinate
chr1:155100550-155102820 
Target genes
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOSL2MA0478.1chr1:155102149-155102160GGGTGACTCAG+6.02
JUNBMA0490.1chr1:155102149-155102160GGGTGACTCAG+6.02
ZNF263MA0528.1chr1:155100671-155100692TTTTCCTCCCCTCACTTCTCC-6.36
ZNF263MA0528.1chr1:155101397-155101418GGAGGAGCAGGGAGAGAAGTG+6.54
ZNF263MA0528.1chr1:155101759-155101780GGAGGAGGAGGGGACAGGAAG+7.15
Number of super-enhancer constituents: 27             
IDCoordinateTissue/cell
SE_06471chr1:155096466-155104728Brain_Hippocampus_Middle
SE_07527chr1:155096600-155104005Brain_Hippocampus_Middle_150
SE_23168chr1:155096831-155104699Colon_Crypt_1
SE_23913chr1:155096865-155102477Colon_Crypt_2
SE_23913chr1:155102493-155103155Colon_Crypt_2
SE_25038chr1:155096824-155103109Colon_Crypt_3
SE_26314chr1:155097879-155104734Duodenum_Smooth_Muscle
SE_26817chr1:155096813-155103510Esophagus
SE_27749chr1:155096773-155104848Fetal_Intestine
SE_28639chr1:155096730-155104902Fetal_Intestine_Large
SE_31531chr1:155096816-155104839Gastric
SE_34608chr1:155099429-155103501HCT-116
SE_35043chr1:155095845-155105030HeLa
SE_36485chr1:155099148-155103878HMEC
SE_40872chr1:155098208-155104773Left_Ventricle
SE_41746chr1:155096958-155103454LNCaP
SE_42320chr1:155096778-155104870Lung
SE_47900chr1:155098283-155103087Pancreas
SE_49199chr1:155097092-155104701Right_Atrium
SE_49607chr1:155100275-155103472Right_Ventricle
SE_50340chr1:155096805-155104715Sigmoid_Colon
SE_52513chr1:155096836-155104823Small_Intestine
SE_56988chr1:155096855-155103515VACO_400
SE_57550chr1:155099144-155103474VACO_503
SE_58142chr1:155097801-155103164VACO_9m
SE_65093chr1:155099051-155104035NHEK
SE_65444chr1:155096946-155105042Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr1155102278155102800
chr1155101105155102178
chr1155102800155102816
Enhancer Sequence
CCTCGAGACT CCCGCTGGCA GCCTGGGCTC CCGGCTGGCA CTACCCCACC GGGATAACTG 60
TCCCGGCCAA ACCCTGAGCT GAGCCTAGAG TAGATGACCG AGGTAGGAGG GCGGCTGTAG 120
ATTTTCCTCC CCTCACTTCT CCGTCATATC TGGGAGCACC CCACCCCGGG GCATGCTTGT 180
GTCTACTTGC ATGGGCTTAT ATCTGCCCTT CCCTTCCTTC TCTCTGGCAC CCCTATTACT 240
CTAAAGTGAG GGACTCATGC TGGGCAGTTC CTGCCTTCAG CATAGACTTC GCCCCTGGCA 300
GCCAGGGCCC TTGTTCCAGG CCCCCCACCC CCCCACTGTG AAAGCCTCCA CGCCTCTCCT 360
TGTGTGTCCT TTGGGTATCT GACCACACTG ACAGATACCT GGTGTGACAT CAAGAGTGCA 420
CAGAATGCTC AAGGTAACCC TGGAAGGACC TCTCAGGAGA GAGCTGGGCT GTAGGCATTC 480
ATTATGCATT CACCCTGTAT TTAAAGCAAA CCTGGAAAGT CCCTCACTAG GGGTCTTTTG 540
GGGTGGCATG AGTGAGGCAC ATGCTGTGCA TGGGTAGGCT GAGGGAATCA CCTGTTTATG 600
GGGCTCTCAA GTAGTAAAAG CGAAGAGCTG GGAGAGGGAG ATCATGGGAA AGCTTCAGAA 660
TGAACAGAAG AGGTTAAAGG GGTTACAGAA GGTTCTGGGC AGGAAGGAGT TAATTTCTCC 720
TGGGCAGGTT TAGGGCTGTG AGGCAAATGG TACTGGGAGG AAGACTCTGT CGGCCCCTTT 780
GTTCTTGCCC TTGAGTTTTC TGAAGTTATG GGAACAATAT TTGAGGGAAT ACAGGAGAGG 840
GTGGTAGGGA GGAGCAGGGA GAGAAGTGGG CAGCTTGGTA TCACGAAAGC CATCTCACCG 900
GCTTAGCCAC TCTCGGCCCT AGCAAGCTTG CCCCCCACTC CCCTTGAGAA ATATGTTGTG 960
CCAGCTTCCT CTGACCCCGT GTCATCGTCT GGTGAGGCAG TCTGTTGTCT GTGGCTTGTT 1020
AGGGTGGGGG AGAGAACAGC CAGCTGCCAA CCCCAGAGGG CAATGCCCTC CTGCCCATGG 1080
ACGCTGGGGA GGCTCAGCCA GCCCTCCGCC ACCCGCTCCC TGTGCTTTGC CTCCTTGACC 1140
TGATGCATCT CGCCCTAGTA TGGGAGAGAG CAAAGTCCCT GTTTATGCCC ATGCCAGGTG 1200
TTGACTGGAG GAGGAGGAGG GGACAGGAAG CCATGAGTAG GGAGGGGGGG ACCCTGGCCT 1260
TTTCCGTTCC CAAGCTCCCA GGTTTCCTCT CTTTCAGGAA GGAGCCTCTT CCTTACCCAC 1320
CTCCCCGCCT TCCCTGACGC CGCTGCCCCC CTTTCCCAGA TGGGGAGCAA GAGTCAAATG 1380
AAGGCTAAGT ACAGCAGACT GTACCCCCAG GAGAGGGGGC TGATGGGTGA CCCTCTGGCC 1440
ACACACACAC ACACACACAC ACACACACAC ACACGCACAC CCTATCATAC CCAGGACTAA 1500
AGAGACGCCA GTCCAGAGTA GAGTCCGTAG GCAGCCAAGC TGGGCCCAGC GTGGGGGCAA 1560
ATATGAGGCT ACAATGAACG GGGTAGGTGA GGCTGGCATG GGTGACTCAG GCCAGTGGGC 1620
AGCAGCCCTG GGATCTCCAG GCCTCAGGCG GGGGCAGCAT GCTGAGAAGG GCGCCAGCCT 1680
CCCTCATGCT GGAGGGCAGG CCCCTCATTC TGACCTGCCA GCTCCCTTTG TTTGGAGGAC 1740
ACTGTTGGGG GTGAGTGGGC GCTGTGCCCT CCTGGGGTCC TGGGGGCTGT GCACATTTGA 1800
CAAGGTAAGT TTTCACAAGT TCTCATGAGT GCTGGGGCGG GTAGCAGAGG TGGATGAGGA 1860
ATGAGTCAGT GCCCGTCACG GGAATGAGGG AAAGACGCCA GGCCCAGAGC TGAAATACCT 1920
GTTCTGAAAT GGCTTCTATG TTTATCTCTC CAGAGAGGAA TTTTAAAAGC CTCTCTCTGC 1980
TCCTCTCTTT TCCCCAGGGT GGGGGAGGGG CCTGGTAAGC CCAGTTTGGG CGCTGGCACG 2040
CTGCTGCAAA GCCTGGCCTC TCAGGGGTCA TGCTGATTGG GCAGTGGGTG CCCACCTCCG 2100
AGTCCTCTCT GCCTGACTCC TTCCTCGCCC TCCCAGCCGT GGCCAGGGCT TTCAGTTCGA 2160
AGCAACTTAG CGCTAATTCT GCTGGGTCTC TAGCTGGCAG TGCCTGGGGG AATTAGAGAA 2220
ACTGACCAGC TTGCGGGGTC GGGGGAAGCA CTTTTCCCCC TACTGGGACC 2270